The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial
Abstract
The aim of the study is to evaluate the effect of a single treatment with the molecular adsorbents recirculating system (MARS) on systemic hemodynamics and oxygen consumption (V O 2) in patients with hyperacute liver failure (HALF). In a controlled design, eight patients with HALF were assigned to a 6-hour MARS treatment, and five patients, to a control group that was mechanically cooled to match the MARS group. Systemic hemodynamic variables were determined hourly during the study period. In the MARS group, systemic vascular resistance index increased by 46% from 1,215 ± 437 to 1,778 ± 710 dynes · s · cm−5 · m−2 (P < .0001), which significantly exceeded a 6% increase in the control group. Mean arterial pressure increased from 69 ± 5 to 83 ± 11 mm Hg in the MARS group (P < .0001) and was unchanged in the control group. Cardiac index decreased by 20% from 4.6 ± 1.8 to 3.7 ± 1.1 L/min · m−2 (P = .0007) in the MARS group and by 7% in the control group. Heart rate decreased from 105 ± 21 to 85 ± 15 beats/min in the MARS group (P < .0001) and was unchanged in the control group. In the MARS group, oxygen delivery decreased from 621 ± 198 to 486 ± 141 mL/min · m−2 (P < .05), and V O 2, from 142 ± 31 to 112 ±21 mL/min · m−2 (P < .05). Arterial lactate and pH levels were unchanged. In conclusion, systemic hemodynamic values tend to normalize, whereas systemic V O 2 decreases during MARS treatment in patients with HALF. These effects cannot be explained by the degree of cooling associated with MARS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585
Cited by
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
Self-citationHassanein, T. I., Tofteng, F., Brown, R. S., McGuire, B., Lynch, P., Mehta, R., Larsen, F. S., Gornbein, J., Stange, J., & Blei, A. T. (2007) · Hepatology · doi:10.1002/hep.21930 · Cited by 407
Self-citationVascular endothelial dysfunction in cirrhosis
Iwakiri, Y., & Groszmann, R. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.006 · Cited by 312
Saliba, F., Camus, C., Durand, F., Mathurin, P., Letierce, A., Delafosse, B., Barange, K., Perrigault, P. F., Belnard, M., Ichaï, P., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-8-201310150-00005 · Cited by 292
Ding, G. K. A., & Buckley, N. A. (2008) · QJM · doi:10.1093/qjmed/hcn077 · Cited by 16
Metadata
- Authors
- Schmidt, L. E., Wang, L. P., Hansen, B. A., & Larsen, F. S.
- Venue
- Liver Transplantation
- Published
- 2003-03
- Volume
- 9
- Issue
- 3
- Pages
- 290-297
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2055025353
- Cited by
- 231
- References
- 2
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. https://app.cochat.ai/papers/10.1053/jlts.2003.50051
- The paper
- Schmidt, L. E., Wang, L. P., Hansen, B. A., & Larsen, F. S. (2003). Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transplantation. https://doi.org/10.1053/jlts.2003.50051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.